Johannes Hausmann1, Alica Kubesch2, Carmen M Goettlich1, Julia Rey3, Astrid Wächtershäuser1, Jörg Bojunga1, Irina Blumenstein1. 1. Department of Internal Medicine 1, Goethe-University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. 2. Department of Internal Medicine 1, Goethe-University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. Alica.Kubesch@kgu.de. 3. Institute of Biostatistics and Math Modeling, Goethe-University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Abstract
BACKGROUND: HNC patients often experience weight loss during treatment. To date, there is only limited data on patient quality of life (QLQ) and subjective benefit of the PEG insertion. OBJECTIVE: To investigate the nutritional status, QLQ, and overall benefit. METHODS: 181 patients fitting our inclusion criteria (01/2012-12/2012) were enrolled. Utilization rate, nutritional status, QLQ, and subjective PEG assessment were determined with electronic charts and the Quality of life-questionnaire (EORTC-QLQ-C30). RESULTS: The utilization rate of the entire cohort was 91.7%. The PEG was used full-time by 149 patients. No statistical differences in QLQ were observed between the groups. Of the patients that used the PEG entirely (99.7%), partially (85.3%) or not all (55.3%) would 99.7%, 85.3 and 55.8% undergo the procedure in the future if necessary. CONCLUSIONS: QLQ was not significantly reduced by insertion. Especially patients using the PEG full-time had an objective and subjective benefit from the inserted PEG tube.
BACKGROUND:HNCpatients often experience weight loss during treatment. To date, there is only limited data on patient quality of life (QLQ) and subjective benefit of the PEG insertion. OBJECTIVE: To investigate the nutritional status, QLQ, and overall benefit. METHODS: 181 patients fitting our inclusion criteria (01/2012-12/2012) were enrolled. Utilization rate, nutritional status, QLQ, and subjective PEG assessment were determined with electronic charts and the Quality of life-questionnaire (EORTC-QLQ-C30). RESULTS: The utilization rate of the entire cohort was 91.7%. The PEG was used full-time by 149 patients. No statistical differences in QLQ were observed between the groups. Of the patients that used the PEG entirely (99.7%), partially (85.3%) or not all (55.3%) would 99.7%, 85.3 and 55.8% undergo the procedure in the future if necessary. CONCLUSIONS: QLQ was not significantly reduced by insertion. Especially patients using the PEG full-time had an objective and subjective benefit from the inserted PEG tube.
Authors: Hans Paul van der Laan; Hendrik P Bijl; Roel J H M Steenbakkers; Arjen van der Schaaf; Olga Chouvalova; Johanna G M Vemer-van den Hoek; Agata Gawryszuk; Bernard F A M van der Laan; Sjoukje F Oosting; Jan L N Roodenburg; Kim Wopken; Johannes A Langendijk Journal: Radiother Oncol Date: 2015-03-16 Impact factor: 6.280
Authors: Frank A Sinicrope; Nathan R Foster; Greg Yothers; Al Benson; Jean Francois Seitz; Roberto Labianca; Richard M Goldberg; Aimery Degramont; Michael J O'Connell; Daniel J Sargent Journal: Cancer Date: 2013-01-10 Impact factor: 6.860
Authors: Miranda E M C Christianen; Irma M Verdonck-de Leeuw; Patricia Doornaert; Olga Chouvalova; Roel J H M Steenbakkers; Phil W Koken; C René Leemans; Sjoukje F Oosting; Jan L N Roodenburg; Bernard F A M van der Laan; Ben J Slotman; Hendrik P Bijl; Johannes A Langendijk Journal: Radiother Oncol Date: 2015-08-25 Impact factor: 6.280
Authors: Giorgio Capuano; Alessandra Grosso; Pier Carlo Gentile; Michele Battista; Federico Bianciardi; Annamaria Di Palma; Ida Pavese; Francesco Satta; Michela Tosti; Anna Palladino; Guido Coiro; Mario Di Palma Journal: Head Neck Date: 2008-04 Impact factor: 3.147
Authors: James A Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K Kian Ang Journal: N Engl J Med Date: 2006-02-09 Impact factor: 91.245
Authors: Arlene A Forastiere; Qiang Zhang; Randal S Weber; Moshe H Maor; Helmuth Goepfert; Thomas F Pajak; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Wade Thorstad; Henry Wagner; John F Ensley; Jay S Cooper Journal: J Clin Oncol Date: 2012-11-26 Impact factor: 44.544
Authors: Matti Sievert; Miguel Goncalves; Benedicta Binder; Sarina K Mueller; Robin Rupp; Michael Koch; Stephan Dürr; Maximilian Traxdorf; Markus Hecht; Heinrich Iro; Antoniu-Oreste Gostian Journal: HNO Date: 2021-05-21 Impact factor: 1.284
Authors: Matti Sievert; Miguel Goncalves; Benedicta Binder; Sarina K Mueller; Robin Rupp; Michael Koch; Stephan Dürr; Maximilian Traxdorf; Markus Hecht; Heinrich Iro; Antoniu-Oreste Gostian Journal: HNO Date: 2021-04-09 Impact factor: 1.284